| Literature DB >> 35710666 |
Ashley E Brown1, Maleka Najmi2, Taylor Duke1, Daniel A Grabell1, Misha V Koshelev1, Kelly C Nelson3.
Abstract
Primary care physicians (PCPs) are often the first line of defense against skin cancers. Despite this, many PCPs do not receive a comprehensive training in skin conditions. Educational interventions aimed at skin cancer screening instruction for PCPs offer an opportunity to detect skin cancer at earlier stages and subsequent improved morbidity and mortality. A scoping review was conducted to collect data about previously reported skin cancer screening interventions for PCPs. A structured literature search found 51 studies describing 37 unique educational interventions. Curriculum elements utilized by the interventions were divided into categories that would facilitate comparison including curriculum components, delivery format, delivery timing, and outcome measures. The interventions varied widely in design, including literature-based interventions, live teaching sessions, and online courses with durations ranging from 5 min to 24 months. While several interventions demonstrated improvements in skin cancer knowledge and competency by written exams, only a few revealed positive clinical practice changes by biopsy review or referral analysis. Examining successful interventions could aid in developing a skin cancer detection curriculum for PCPs that can produce positive clinical practice and population-based changes in the management of skin cancer.Entities:
Keywords: Cancer screening; Dermoscopy; Detection of cancer; Early detection; Family doctor; GP; General practitioner; Melanoma; PCP; Primary care physician; Primary care provider; Secondary prevention; Skin cancer screening
Mesh:
Year: 2022 PMID: 35710666 PMCID: PMC9202989 DOI: 10.1007/s11606-022-07501-9
Source DB: PubMed Journal: J Gen Intern Med ISSN: 0884-8734 Impact factor: 6.473
Inclusion and exclusion criteria for article selection
• Studies examining some aspects of skin cancer educational training aimed at PCPs. • Participants, or intended participants, were primarily (>50%) PCPs, including family doctors, family medicine residents, general practitioners, internal medicine physicians in primary care, and nurse practitioners or physician assistants who practice in primary care. • Skin cancer was defined to include melanoma, basal cell carcinoma, and squamous cell carcinoma; studies did not have to instruct on all three listed skin cancers for inclusion. | |
• General reviews of dermatology, with less than 50% dedicated to skin cancer. • Participants were primarily (>50%) medical students, dermatologists, patients, or residents in specialties other than the above; studies that use dermatologists as a control cohort were an exception to this criterion. • Studies utilizing decision-making software (artificial or augmented intelligence). • Teledermatology studies in which dermatologists interpreted clinical or dermoscopic pictures. • Duplicate publication in the form of a conference abstract |
Definitions of study variables
| Criteria | Specifics | Definition |
|---|---|---|
| Curriculum | Epidemiology | Provided background information on skin cancer, trends in incidence or mortality, risk factors (skin types, family history, sun exposure, etc.) |
| Pigmented lesions | Taught basic principles of recognizing melanoma and differentiating benign pigmented lesions | |
| Non-pigmented lesions | Taught basic principles of recognizing squamous cell carcinoma or basal cell carcinoma and differentiating benign non-pigmented lesion | |
| Dermoscopy | Instructed participants on use of dermoscopy in recognizing skin cancer and/or addition of dermoscopy to skin exam | |
| Algorithm | Used a novel or pre-existing clinical (ex: ABCDE) or dermoscopic (ex: 3-point checklist) algorithm to aid in triage of skin lesions | |
| Management | Instructed participants on determining a plan of action for skin lesion (biopsy, observation, referral, etc.) | |
| Counseling | Instructed participants on prevention strategies for patients including photoprotection, skin self-examination, and/or follow-up | |
| Delivery format | Live | Participants attended a training session in person; included speaker given large lectures or small group sessions |
| Literature | Provision of educational books, pamphlets, posters, cards, etc. | |
| E-learning | Use of computer software, multimedia, or the internet. Ranged from video lectures to interactive training curriculums | |
| Feedback | Simultaneous or delayed feedback given to participants. Included review of biopsies or review of written assessments with comments provided to the learner | |
| Interactive | Requires cognitive engagement for participation. Ranges from intermittent practice quizzes to participant-guided learning | |
| Patient interaction | Included interaction with real or standardized patients; either as demonstration or for procedure clinics | |
| Delivery timing | Synchrony | Synchronous interventions are delivered at the same time to an audience, while asynchronous interventions vary in timing of delivery based on an individual completing a task. |
| Day | Training delivered over one or multiple days. If training took place individually based off the minimum time to finish the intervention, or average reported by paper | |
| Length | Cumulative length of intervention if available. If over multiple days, total span included. If training took place individually based off the minimum time to finish the intervention, or average completion time if provided by paper | |
| Assessment type | Pre-test | Exam given before intervention takes place, either immediately or at some time interval before |
| Immediate post-test | Exam given immediately after completion of an intervention | |
| Spaced post-test | Exam given at a spaced time interval following intervention completion. Either set or averaged time interval specified. | |
| Biopsy review | Biopsies performed by participants audited to determine diagnostic accuracy | |
| Other clinical measure | Included patient or physician interviews, electronic medical record (EMR) review, referral analysis, dermoscopic image comparison | |
| Outcome measures | Knowledge | Objective report of conceptual understanding of skin cancer (ex: risk factor identification) determined via a written exam |
| Competence | Objective report of clinical skills (ex: diagnostic accuracy) determined via a written exam | |
| Self-efficacy | Subjective report of confidence in, attitude towards, or beliefs about skin cancer diagnosis and management | |
| Diagnostic performance | Objective assessment of diagnostic abilities in a clinical practice setting through biopsy review or referral analysis with expert evaluation | |
| Systems outcomes | Subjective or objective assessment of behaviors in practice and/or effects on patients (ex: number of TBSE performed, referral patterns) |
Fig. 1PRISMA flowchart of literature search and study selection process. aPubMed yield = 142, Scopus yield = 442, EMBASE yield = 187.
Study characteristics. Interventions chronologically from the first year described. If the intervention name was specified in the paper, it was included, and all interventions assigned a numerical value based off chronological order. aIf participants were divided into intervention and control, intervention is mentioned first. bDesign categories: B/A before and after, A after only, C controlled, RCT randomized controlled trial, I intervention only
| Intervention | Author, year | Location | Participantsa | Designb |
|---|---|---|---|---|
| 1. Newcastle Melanoma Unit GP Training | Girgis, 1995[ | Australia | 24,17 | B/A; C |
| Burton, 1998[ | Australia | 31, 32 | A; C | |
| 2. Algorithm and instant camera | Del Mar, 1995[ | Australia | 53, 52 | RCT |
| English, 2003[ | Australia | 245, 228 | RCT | |
| 3. NSW Cancer Council seminar | Ward, 1995[ | Australia | 147 | B/A |
| 4 | Laidlaw, 1996[ | UK | 980 | I |
| 5 | Dolan, 1997[ | USA | 46, 36 | RCT |
| 6. Skin cancer triage | Gerbert, 1998[ | USA | 26, 26 | RCT |
| Gerbert, 2002[ | USA | 39, 32 | RCT | |
| 7. Melanoma education for primary care | Harris, 1999[ | USA | 17 | B/A |
| Harris, 2001[ | USA | 354 | B/A | |
| Harris, 2001[ | UK | 150 | B/A | |
| 8. SkinWatch | Raasch, 2000[ | Australia | 23, 23 | RCT |
| Youl, 2007[ | Australia | 16 | B/A | |
| 9 | Westerhoff, 2000[ | Australia | 37, 37 | RCT |
| 10 | Brochez, 2001[ | Belgium | 146 | B/A |
| 11 | Bedlow, 2001[ | UK | 17 | B/A |
| 12. Basic skin cancer triage | Mikkilineni, 2001[ | USA | 22 | B/A |
| Mikkilineni, 2002[ | USA | 23 | B/A | |
| Markova, 2013[ | USA | 21, 30 | RCT | |
| 13 | De Gannes, 2004[ | Canada | 10, 17 | RCT |
| 14 | Carli, 2005[ | Italy | 41 | B/A |
| 15 | Dolianitis, 2005[ | Australia | 61 | A |
| 16 | Argenziano, 2006[ | Italy, Spain | 36, 37 | RCT |
| 17 | Menzies, 2009[ | Australia | 63 | B/A |
| 18 | Peuvrel, 2009[ | France | 210 | A |
| 19 | Shariff, 2010[ | UK | 94 | B/A |
| 20. MinSKIN | Badertscher, 2011[ | Switzerland | N/A | I |
| Badertscher, 2013[ | Switzerland | 78 | B/A | |
| Badertscher, 2015[ | Switzerland | 39, 39 | RCT | |
| 21 | Bradley, 2012[ | USA | 6 | B/A |
| 22. INFORMED | Shaikh, 2012[ | USA | N/A | I |
| Eide, 2013[ | USA | 54 | B/A | |
| Weinstock, 2016[ | USA | 101, 21, Unknown | B/A, C | |
| Swetter, 2017[ | USA | 5 | B/A | |
| 23 | Grange, 2014[ | France | 398 | B/A, C |
| 24 | Koelink, 2014[ | The Netherlands | 27, 26 | RCT |
| 25. GP Skin Cancer Referral toolkit | Gulati, 2015[ | UK | 8163 | B/A |
| 26 | Hartnett, 2016[ | USA | 10 | B/A |
| 27 | Anders, 2017[ | Germany | 573 | B/A |
| 28 | Secker, 2017[ | The Netherlands | 293 | B/A |
| 29 | Beecher, 2018[ | Ireland | 23 | B/A |
| 30 | Duarte, 2018[ | Portugal | Unknown | A |
| 31. Longitudinal curriculum with procedure clinic | Rivet, 2018[ | Canada | 60 | B/A, C |
| 32. Mastery learning | Robinson, 2018[ | USA | 44, 45 | RCT |
| Robinson, 2018[ | USA | 44, 45 | A | |
| 33 | Augustsson, 2019[ | Sweden | 27, 16 | B/A, C |
| 34. Triage Amalgamated Dermoscopic Algorithm (TADA) | Seiverling, 2019[ | USA | 59 | B/A |
| 35. Five-point checklist for skin cancer detection in primary care | Moscarella, 2019[ | Italy | N/A | I |
| 36 | Harkemanne, 2020[ | Belgium | 56 | B/A |
| 37. Suspicious Skin Lesions | Marra, 2020[ | The Netherlands | 83, 102 | A; C |
Fig. 2a Number of publications per year, b cumulative number of publications.
Curriculum elements
| Intervention | Epidemiology | Pigmented lesions | Non-pigmented lesions | Dermoscopy | Algorithm | Management | Counseling |
|---|---|---|---|---|---|---|---|
| 1[ | X | X | X | ||||
| 2[ | X | X | X | ||||
| 3[ | X | X | X | X | |||
| 4[ | X | X | X | ||||
| 5[ | X | X | X | X | |||
| 6[ | X | X | X | X | X | ||
| 7[ | X | X | X | X | X[ | ||
| 8[ | X[ | X | X[ | X[ | X[ | X | |
| 9[ | X | X | X | ||||
| 10[ | X | X | X | ||||
| 11[ | X | X | |||||
| 12[ | X | X | X | X | X | X | |
| 13[ | X | X | X | X | X | ||
| 14[ | X | X | X | X | |||
| 15[ | X | X | X | ||||
| 16[ | X | X | X | X | |||
| 17[ | X | X | |||||
| 18[ | X | X | X | X | X | ||
| 19 [ | X | X | |||||
| 20[ | X | X | X | X[ | X | ||
| 21[ | X | X | X | X | X | ||
| 22[ | X | X | X | X[ | X | X | X |
| 23[ | X | X | X | X | |||
| 24[ | X | X | X | X | X | ||
| 25[ | X | X | X | ||||
| 26[ | X | X | X | ||||
| 27[ | X | X | X | X | X | ||
| 28[ | X | X | X | ||||
| 29[ | X | X | X | ||||
| 30[ | X | X | X | X | |||
| 31[ | X | X | X | X | X | ||
| 32[ | X | X | X | X | X | ||
| 33[ | X | X | X | X | |||
| 34[ | X | X | X | X | |||
| 35[ | X | X | X | X | X | ||
| 36[ | X | X | X | ||||
| 37[ | X | X | X | X | X |
Delivery format and timing. aSynchrony: A asynchronous, S synchronous. bFor events that finished in variable time, the shortest length to finish is finished. Others are estimated by CME hour credit or given as averaged time. cIntervention had 3 groups with different types of teaching style, one of which was interactive
| Intervention | Live | Literature | E-learning | Feedback | Patient interaction | Interactive | Synchronya | Days | Lengthb |
|---|---|---|---|---|---|---|---|---|---|
| 1[ | X | X | A | Multiple | >6 h | ||||
| 2[ | X | A | Multiple | 24 months[ 10 months[ | |||||
| 3[ | X | X | S | Single | ~8 h | ||||
| 4[ | X | A | Untimed | Untimed | |||||
| 5[ | X | S | Single | 2 h | |||||
| 6[ | X[ | X | X[ | X | X | A | Multiple | >3 h [ >1 h[ | |
| 7[ | X | X | X | A | Single or multiple | 1 h[ 6 h[ 18 h[ | |||
| 8[ | X | A | Multiple | 3 weeks[ 6 months[ | |||||
| 9[ | X | X | S | Single | 1 h | ||||
| 10[ | X | X | S | Single | 2 h | ||||
| 11[ | X | X | S | Single | Not specified | ||||
| 12[ | X[ | X[ | X[ | X[ | S | Single | 2 h | ||
| 13[ | X | S | Single | 12 min | |||||
| 14[ | X | S | Single | 4 h | |||||
| 15[ | X | X | X | A | Single | Untimed | |||
| 16[ | X | S | Single | 4 h | |||||
| 17[ | X | X | X | X | A | Multiple | >2 h | ||
| 18[ | X | X | S | Single | 2 h | ||||
| 19 [ | X | A | Untimed | Untimed | |||||
| 20[ | X | X[ | X | S | Multiple[ Single[ | 12 months[ ~8 h[ | |||
| 21[ | X | X | S | Single | 45 min | ||||
| 22[ | X | X | A | Single | 1–2 h | ||||
| 23[ | X | X | X | X | S | Single | 2.5 h | ||
| 24[ | X | S | Multiple | 10 h | |||||
| 25[ | X | X | A | Single or multiple | >5 min | ||||
| 26[ | X | S | Single | 15 min | |||||
| 27[ | X | X | X | X | S | Single | 8 h | ||
| 28[ | X | X | X | A | Single | 1 day | |||
| 29[ | X | S | Single | 1 h | |||||
| 30[ | X | X | S | Single | 3 h | ||||
| 31[ | X | X | X | X | X | X | A | Multiple | 8 months |
| 32[ | X | X | X | A | Multiple | 9 weeks | |||
| 33[ | X | X | S | Single | 5 h | ||||
| 34[ | X | Xc | S | Single | 75 min | ||||
| 35[ | X | N/A | N/A | N/A | |||||
| 36[ | X | S | Single | 2 h | |||||
| 37[ | X | X | A | Single or multiple | >2 h |
Assessment types and outcome measures. aKey: + = statistically significant improvement; − = no statistical improvement; +* = improvement, no statistics performed; −* = no improvement, no statistics. bStatistically significant difference in physician reported TBSE after 1 month, difference not present at 12 months post-intervention
| Intervention | Assessment type | Outcome measures a | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Author, year | Pre-test | Immediate post-test | Spaced post-test | Biopsy review | Other clinical measures | Knowledge | Competence | Self-efficacy | Diagnostic performance | Systems outcomes | |
| 1 | Girgis, 1995[ | X | X | X | X | + | + | − | + | ||
| Burton, 1998[ | X | − | |||||||||
| 2 | Del Mar, 1995[ | X | + | ||||||||
| English, 2003[ | − | + | |||||||||
| 3 | Ward, 1995[ | X | 3 months | X | + | + | + | ||||
| 4 | Laidlaw, 1996[ | ||||||||||
| 5 | Dolan, 1997[ | X | 1 month | X | + | − | − | + | |||
| 6 | Gerbert, 1998[ | X | 3 weeks | + | |||||||
| Gerbert, 2002[ | X | X | 8 weeks | + | +* | ||||||
| 7 | Harris, 1999[ | X | X | − | + | + | |||||
| Harris, 2001[ | X | X | + | + | + | ||||||
| Harris, 2001[ | X | X | + | + | + | ||||||
| 8 | Raasch, 2000[ | X | − | − | + | ||||||
| Youl, 2007[ | X | + | |||||||||
| 9 | Westerhoff, 2000[ | X | 23 days | + | |||||||
| 10 | Brochez, 2001[ | X | X | + | +* | ||||||
| 11 | Bedlow, 2001[ | X | 2 weeks | + | |||||||
| 12 | Mikkilineni, 2001[ | X | X | X | + | + | |||||
| Mikkilineni, 2002[ | X | 1 month | + | + | + | ||||||
| Markova, 2013[ | X | + | +/−b | ||||||||
| 13 | De Gannes, 2004[ | X | 6 months | X | − | − | − | − | |||
| 14 | Carli, 2005[ | X | X | + | |||||||
| 15 | Dolianitis, 2005[ | X | + | ||||||||
| 16 | Argenziano, 2006[ | X | + | ||||||||
| 17 | Menzies, 2009[ | X | X | X | X | + | + | + | |||
| 18 | Peuvrel, 2009[ | 15 months | X | +* | +* | ||||||
| 19 | Shariff, 2010[ | X | − | − | |||||||
| 20 | Badertscher, 2011[ | X | X | 1 year | |||||||
| Badertscher, 2013[ | X | X | + | ||||||||
| Badertscher, 2015[ | X | X | 1 year | − | |||||||
| 21 | Bradley, 2012[ | X | X | X | + | + | +* | + | |||
| 22 | Shaikh, 2012[ | ||||||||||
| Eide, 2013[ | X | X | 6 months | X | + | +* | + | ||||
| Weinstock, 2016[ | X | + | + | ||||||||
| Swetter, 2017[ | X | − | + | ||||||||
| 23 | Grange, 2014[ | X | X | + | + | +* | + | ||||
| 24 | Koelink, 2014[ | X | X | − | +* | ||||||
| 25 | Gulati, 2015[ | X | X | +* | −* | + | − | ||||
| 26 | Hartnett, 2016[ | X | X | + | + | +* | |||||
| 27 | Anders, 2017[ | X | X | + | + | + | |||||
| 28 | Secker, 2017[ | X | 3 months | + | |||||||
| 29 | Beecher, 2018[ | X | 3 months | + | |||||||
| 30 | Duarte, 2018[ | X | − | +* | |||||||
| 31 | Rivet, 2018[ | X | X | X | +* | +* | |||||
| 32 | Robinson, 2018[ | X | X | X | + | + | |||||
| Robinson, 2018[ | X | +* | |||||||||
| 33 | Augustsson, 2019[ | X | X | 6 months | + | ||||||
| 34 | Seiverling, 2019[ | X | X | + | |||||||
| 35 | Moscarella, 2019[ | ||||||||||
| 36 | Harkemanne, 2020[ | X | X | + | |||||||
| 37 | Marra, 2020[ | X | + | + | |||||||